Geneva Capital Management LLC Sells 1,140 Shares of Azenta, Inc. (NASDAQ:AZTA)

Geneva Capital Management LLC cut its position in Azenta, Inc. (NASDAQ:AZTA) by 0.2% in the third quarter, HoldingsChannel.com reports. The firm owned 494,710 shares of the company’s stock after selling 1,140 shares during the period. Geneva Capital Management LLC’s holdings in Azenta were worth $23,964,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Hantz Financial Services Inc. bought a new stake in shares of Azenta in the 2nd quarter valued at about $30,000. Farther Finance Advisors LLC lifted its position in Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after acquiring an additional 256 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Azenta by 150.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after acquiring an additional 955 shares in the last quarter. Lazard Asset Management LLC purchased a new position in Azenta in the first quarter worth $130,000. Finally, Acadian Asset Management LLC increased its position in shares of Azenta by 24.7% during the first quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after purchasing an additional 471 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Needham & Company LLC reissued a “buy” rating and issued a $69.00 price objective on shares of Azenta in a research report on Wednesday, August 7th. Evercore ISI lowered their price target on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Azenta has an average rating of “Hold” and a consensus price target of $66.40.

Insiders Place Their Bets

In other news, CFO Herman Cueto sold 1,595 shares of the stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $43.68, for a total value of $69,669.60. Following the transaction, the chief financial officer now directly owns 24,604 shares of the company’s stock, valued at approximately $1,074,702.72. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.77% of the stock is currently owned by insiders.

Azenta Price Performance

Shares of AZTA opened at $45.99 on Wednesday. The company’s fifty day moving average price is $45.83 and its 200-day moving average price is $50.64. Azenta, Inc. has a 1-year low of $40.24 and a 1-year high of $69.16.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.